Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China
· Delayed Price · Currency is CNY 16.13
+0.07 (0.44%)
Apr 30, 2026, 11:29 AM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 2.68 billion as of April 29, 2026. Its market cap has decreased by -35.95% in one year.
Market Cap
2.68B
Enterprise Value
2.51B
Revenue
418.18M
Ranking
n/a
PE Ratio
48.72
Stock Price
16.13
Market Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 2.68B, a decrease of -51.65%. That is a compound annual growth rate of -10.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Sito Bio-technology | 2.67B |
| Suzhou Fushilai Pharmaceutical | 2.61B |
| Shanghai Universal Biotech | 2.60B |
| Jilin Jian Yisheng Pharmaceutical | 2.70B |
| Hubei Goto Biopharm | 2.72B |
| Shanghai Hile Bio-Technology | 2.51B |
| Zhejiang East Asia Pharmaceutical | 2.37B |
| Jiangsu Sihuan Bioengineering | 3.02B |